Bioxcel Therap (BTAI.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Nov13

Bioxcel Therap released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 98K (forecast USD 216.67K), actual EPS USD -2.1774 (forecast USD -1.34)

04:00

Bioxcel Therap released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 386K, actual EPS USD -6.1244

04:00

Oct16

Selvaraju focuses on healthcare stocks such as Bioxcel Therapeutics

13:02

Sep10

BioXcel Therapeutics Announces Positive Results for BXCL501 Phase 3 Trial

10:32

Aug26

BioXcel Therapeutics to Announce Preliminary Results of Serenity Phase 3 Safety Trial

20:01

Aug18

BioXcel Therapeutics Inc. Launches ATM Program to Sell Up to $80 Million in Common Stock

21:16

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 98 K, Net Income -30.91 M, EPS -2.1774

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 120 K, Net Income -19.19 M, EPS -2.4463

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 168 K, Net Income -7.254 M, EPS -1.5006

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More